Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This observational study is conducted in Europe. The objective of this retrospective
observational cohort analysis is to assess the changes of glycaemic control and quality of
care in those Type 2 diabetic patients who were previously treated with Mixtard® insulins
after 6 months of their switch to analog premix insulin NovoMix® 30 therapy.